title: Clinical evaluation of a (1,3)-beta-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients.
abstract: (1,3)-beta-d-Glucan (BG) is a component of the Pneumocystis jiroveci cell wall. Thirty-one immunocompromised patients with pneumonia (16 with presumptive pneumocystis pneumonia [PCP] and 15 with non-PCP) were evaluated for serum BG levels. Serum from all 16 presumptive PCP patients and from 2/15 patients with non-PCP was positive for BG. Results indicate that BG is a reliable marker for diagnosing PCP.
authors.affiliation: Clinica Malattie Infettive, Azienda Ospedaliera Universitaria San Martino, Genoa, Italy. valerio.delbono@hsanmartino.it
authors.forename: Valerio
authors.initials: V
authors.lastname: Del Bono
authors.forename: Alessandra
authors.initials: A
authors.lastname: Mularoni
authors.forename: Elisa
authors.initials: E
authors.lastname: Furfaro
authors.forename: Emanuele
authors.initials: E
authors.lastname: Delfino
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Rosasco
authors.forename: Franca
authors.initials: F
authors.lastname: Miletich
authors.forename: Claudio
authors.initials: C
authors.lastname: Viscoli
mesh_terms: D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D002473:Cell Wall / Q000737:chemistry; D006801:Humans; D016867:Immunocompromised Host; D045363:Pneumocystis carinii / Q000276:immunology / Q000302:isolation & purification; D011020:Pneumonia, Pneumocystis / Q000175:diagnosis* / Q000276:immunology / Q000382:microbiology; D011509:Proteoglycans; D047071:beta-Glucans / Q000097:blood*
chemical_list: D015415:Biomarkers; D011509:Proteoglycans; D047071:beta-Glucans; C010770:polysaccharide-K
references.citation: Clin Infect Dis. 2005 Sep 1;41(5):654-9
references.pmid: 16080087
references.citation: Clin Infect Dis. 2004 Jul 15;39(2):199-205
references.pmid: 15307029
references.citation: Ann Intern Med. 2007 Jul 3;147(1):70-2
references.pmid: 17606968
references.citation: BMC Infect Dis. 2009 Apr 22;9:47
references.pmid: 19383170
references.citation: MMWR Recomm Rep. 1992 Dec 18;41(RR-17):1-19
references.pmid: 1361652
references.citation: J Clin Microbiol. 2005 Jan;43(1):299-305
references.pmid: 15634986
references.citation: Intern Med. 2009;48(4):195-202
references.pmid: 19218768
references.citation: Clin Infect Dis. 2008 Jun 15;46(12):1930-1
references.pmid: 18540808
references.citation: J Clin Microbiol. 2005 Dec;43(12):5957-62
references.pmid: 16333082
references.citation: Antimicrob Agents Chemother. 2006 Oct;50(10):3450-3
references.pmid: 17005829
references.citation: Clin Infect Dis. 2008 Mar 15;46(6):878-85
references.pmid: 18260755
references.citation: Infection. 2009 Jun;37(3):261-5
references.pmid: 19148577
references.citation: N Engl J Med. 2004 Jun 10;350(24):2487-98
references.pmid: 15190141
references.citation: J Clin Microbiol. 2008 Mar;46(3):1009-13
references.pmid: 18160456
references.citation: Clin Infect Dis. 2008 Jun 15;46(12):1864-70
references.pmid: 18462174